Buprenorphine And Naloxone 31722-0482
Product NDC
31722-0482- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Film, Soluble
- Route
- Buccal And Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- May 1, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA219850
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 12 mg/1 |
| Naloxone Hydrochloride | 3 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
30 POUCH in 1 CARTON (31722-482-30) / 1 FILM, SOLUBLE in 1 POUCH (31722-482-31)